South African study of blast phase chronic myeloid leukaemia: A poor prognostic outlook

BACKGROUND: Chronic myeloid leukaemia (CML) is a haematological malignancy characterised by the translocation t(9;22)(q34;q11.2), resulting in a constitutively active tyrosine kinase. Globally, overall survival of blast crisis phase (BC) CML is one year. Newer tyrosine kinase inhibitors and allogene...

Descripción completa

Detalles Bibliográficos
Autores principales: Hodkinson, Katherine E., Bouwer, Nikki, Vaughan, Jenifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210180/
https://www.ncbi.nlm.nih.gov/pubmed/35747555
http://dx.doi.org/10.4102/ajlm.v11i1.1578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210180/
https://www.ncbi.nlm.nih.gov/pubmed/35747555
http://dx.doi.org/10.4102/ajlm.v11i1.1578

Ejemplares similares